(E)-2-(3,5-Dihydroxyphenyl)-1-(4-hydroxyphenyl)ethene (E)-3,4′,5-Trihydroxystilbene (E)-5-(p-Hydroxystyryl)resorcinol (E)-Resveratrol 1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]- 1,3-Benzenediol, 5-[2-(4-hydroxyphenyl)ethenyl]-, (E)- 3,4',5'-TRIHYDROXY-TRANS-STILBENE 3,4',5-TRIHYDROXY-TRANS-STILBENE 3,4′,5-Stilbenetriol 3,4′,5-Trihydroxystilbene 3,4′,5-Trihydroxy-trans-stilbene 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol Biofort CA 1201 Cuspidatin Melinjo Resveratrol 20 Polygonin Regu-Fade Resveratrol P 5 RESVERATROLE Resvida SRT 501 SRT 501M TRANS-1,2-(3,4',5-TRIHYDROXYDIPHENYL)ETHYLENE TRANS-3,4,5-TRIHYDROXYSTILBENE trans-3,5,4′-Trihydroxystilbene TRANS-3,5,4'-STILBENETRIOL TRANS-RESVERATROL Vineatrol 20M
Mutation data reported. When heated to decomposition, it emits acrid smoke and irritating vapors.
Hazard Codes:?Xi
Risk Statements: 37/38-41-36/38?
R37/38:Irritating to respiratory system and skin.?
R41:Risk of serious damage to the eyes.?
R36/38:Irritating to eyes and skin.
Safety Statements: 26-39-37/39?
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.?
S39:Wear eye / face protection.?
S37/39:Wear suitable gloves and eye/face protection.
WGK Germany: 3
RTECS: CZ8987000
?Resveratrol , its cas register number is 501-36-0. It also can be called 3,4',5-Trihydroxy-trans-stilbene ; and 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol .?Resveratrol (CAS NO.501-36-0) sholud be kept tightly closed or stored at correct temperature. Th first aid measures are as follow: When in the eyes, hold eyelids apart and flush eyes with plenty of water. After initial flushing, remove any contact lenses and continue flushing for at least 20 minutes. Have eyes examined and tested by medical personnel.?If it was?inhaled: Remove from exposure and move to fresh air immediately. Give artificial respiration while not breathing. When breathing is difficult, give oxygen. And get medical aid immediately. If swallowed, wash out mouth with water provided person is conscious. Never give anything by mouth to an unconscious person. Get medical attention. Do not induce vomiting unless directed to do so by medical personnel.?
1. | ??? |
dni-hmn-oth 30 μmol/L/24H |
??? | CALEDQ ?? Cancer Letters (Shannon, Ireland). 163 (2001),49. |
2. | ??? |
dni-hmn-leu 20 μmol/l/8H |
??? | CALEDQ ?? Cancer Letters (Shannon, Ireland). 140 (1999),1. |
3. | ??? |
sce-ham-lvr 10?mg/L/48H |
??? | MUREAV ?? Mutation Research. 494 (2001),107. |
4. | ??? |
cyt-ham-lvr 10?mg/L/48H |
??? | MUREAV ?? Mutation Research. 494 (2001),107. |
5. | ??? |
mnt-ham-lvr 10?mg/L/48H |
??? | MUREAV ?? Mutation Research. 494 (2001),107. |
Eye irritation, Category 2
Pictogram(s) | |
---|---|
Signal word | Warning |
Hazard statement(s) | H319 Causes serious eye irritation |
Precautionary statement(s) | |
Prevention | P264 Wash ... thoroughly after handling. P280 Wear protective gloves/protective clothing/eye protection/face protection. |
Response | P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 If eye irritation persists: Get medical advice/attention. |
Storage | none |
Disposal | none |
none